| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.67B | 136.11B | 107.33B | 95.73B | 96.89B | 94.52B |
| Gross Profit | 53.25B | 49.34B | 50.45B | 45.63B | 40.80B | 37.47B |
| EBITDA | 23.82B | 25.32B | 23.29B | 21.42B | 19.29B | 17.56B |
| Net Income | 16.66B | 17.62B | 16.29B | 14.81B | 13.02B | 12.25B |
Balance Sheet | ||||||
| Total Assets | 86.79B | 100.75B | 83.38B | 74.21B | 69.46B | 57.86B |
| Cash, Cash Equivalents and Short-Term Investments | 16.91B | 24.41B | 21.52B | 12.01B | 13.38B | 12.18B |
| Total Debt | 6.99B | 5.57B | 5.54B | 5.28B | 6.08B | 4.79B |
| Total Liabilities | 44.73B | 55.81B | 40.72B | 32.52B | 29.90B | 23.81B |
| Stockholders Equity | 40.52B | 42.10B | 39.75B | 38.32B | 37.99B | 33.48B |
Cash Flow | ||||||
| Free Cash Flow | 5.59B | 17.52B | 12.02B | 12.83B | 12.37B | 8.84B |
| Operating Cash Flow | 7.01B | 20.71B | 13.63B | 14.36B | 14.19B | 10.16B |
| Investing Cash Flow | 6.00B | -10.49B | -6.21B | 1.76B | -8.65B | 4.25B |
| Financing Cash Flow | -12.03B | -9.39B | -6.49B | -15.42B | -5.60B | -12.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹81.34B | 43.68 | ― | ― | 20.72% | 57.65% | |
75 Outperform | ₹1.07T | 59.91 | ― | 1.42% | 25.67% | 8.14% | |
75 Outperform | ₹760.67B | 40.09 | ― | 1.62% | 5.01% | 7.14% | |
73 Outperform | ₹5.21T | 34.67 | ― | 1.84% | 3.84% | 41.23% | |
69 Neutral | ₹175.79B | 22.54 | ― | 1.91% | -0.78% | -3.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.03T | 55.41 | ― | 1.67% | 7.81% | 0.51% |